Showing results (31-40 of 64) with videos related to
Sort By:
Pageof 7
Oncology Reports|November 29, 2021
[Retracted] Synergistic effects of co‑expression plasmid‑based ADAM10‑specific siRNA and GRIM‑19 on hepatocellular carcinoma in vitro and in vivoSongyang Liu, Wei Zhang, Kai Liu, et al.Journal of Clinical and Translational Hepatology|May 19, 2021
Safety and Efficacy of Physical Thermal Ablation Combined Sorafenib for Hepatocellular Carcinoma: A Meta-analysisMengdi Jin, Qiong Yu, Yahui Liu, et al.Computers in Biology and Medicine|February 1, 2024
MS-TCNet: An effective Transformer-CNN combined network using multi-scale feature learning for 3D medical image segmentationYu Ao, Weili Shi, Bai Ji, et al.Oncology Letters|April 10, 2020
Neuroendocrine tumors of the gallbladderChunyuan Niu, Shupeng Wang, Qingchun Guan, et al.Oncology Reports|February 11, 2017
miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinomaYahui Liu, Wei Zhang, Songyang Liu, et al.International Journal of Medical Sciences|December 17, 2019
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cellsHongqiao Cai, Yang Yang, Fenghui Peng, et al.Heliyon|March 27, 2024
Application of the superior mesenteric artery-first approach in laparoscopic pancreatoduodenectomy: A literature reviewJianji Ke, Feiqi Liu, Jianjia Ke, et al.Oncology Reports|September 23, 2014
Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivoSongyang Liu, Wei Zhang, Kai Liu, et al.International Journal of Oncology|August 7, 2014
miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinomaKai Liu, Songyang Liu, Wei Zhang, et al.Oncology Reports|September 14, 2022
[Retracted] miR‑365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinomaYahui Liu, Wei Zhang, Songyang Liu, et al.Pageof 7